Vir Biotechnology (VIR) Return on Sales (2019 - 2025)
Historic Return on Sales for Vir Biotechnology (VIR) over the last 8 years, with Q3 2025 value amounting to 679.75%.
- Vir Biotechnology's Return on Sales fell 5899600.0% to 679.75% in Q3 2025 from the same period last year, while for Sep 2025 it was 29.64%, marking a year-over-year decrease of 228500.0%. This contributed to the annual value of 7.03% for FY2024, which is 1000.0% up from last year.
- Vir Biotechnology's Return on Sales amounted to 679.75% in Q3 2025, which was down 5899600.0% from 91.4% recorded in Q2 2025.
- In the past 5 years, Vir Biotechnology's Return on Sales registered a high of 1.07% during Q3 2021, and its lowest value of 679.75% during Q3 2025.
- In the last 5 years, Vir Biotechnology's Return on Sales had a median value of 6.91% in 2023 and averaged 61.28%.
- In the last 5 years, Vir Biotechnology's Return on Sales soared by 859000bps in 2022 and then crashed by -5899600bps in 2025.
- Vir Biotechnology's Return on Sales (Quarter) stood at 0.65% in 2021, then crashed by -418bps to 2.06% in 2022, then crashed by -236bps to 6.91% in 2023, then fell by -22bps to 8.45% in 2024, then plummeted by -7942bps to 679.75% in 2025.
- Its Return on Sales stands at 679.75% for Q3 2025, versus 91.4% for Q2 2025 and 39.9% for Q1 2025.